CNOOC Ltd. (CEO) announced a profit for its nine months that Increased, from last year
The company's bottom line came in at RMB119.118 billion, or RMB2.51 per share. This compares with RMB101.971 billion, or RMB2.14 per share, last year.
The company's revenue for the period rose 13.8% to RMB355.574 billion from RMB312.503 billion last year.
CNOOC Ltd. earnings at a glance (GAAP) :
-Earnings: RMB119.118 Bln. vs. RMB101.971 Bln. last year.-EPS: RMB2.51 vs. RMB2.14 last year.-Revenue: RMB355.574 Bln vs. RMB312.503 Bln last year.
For comments and feedback contact: [email protected]
October 27, 2026 07:42 ET November brings a new lineup of FDA regulatory milestones that could influence biotech stocks. This video highlights five biotech companies to watch ahead of their upcoming FDA decisions, spanning potential treatments for sickle cell disease, psychiatric disorders, cardiovascular conditions, and cancer.